GlaxoSmithKline S.A.E (EGX: BIOC)
Egypt
· Delayed Price · Currency is EGP 37.91
-0.15 (-0.39%)
At close: Feb 4, 2025
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 3.15 billion as of February 5, 2025. Its market cap has increased by 4.06% in one year.
Market Cap
3.15B
Enterprise Value
3.57B
Revenue
2.81B
Ranking
n/a
PE Ratio
26.35
Stock Price
37.91
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.15B, an increase of 453.19%. That is a compound annual growth rate of 9.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Commercial International Bank (Egypt) S.A.E | 232.98B |
| El Sewedy Electric Company | 172.22B |
| Talaat Moustafa Group Holding | 110.75B |
| Eastern Company S.A.E | 83.70B |
| Misr Fertilizer Production Company | 83.21B |
| Ezz Steel Company (S.A.E) | 70.76B |
| Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 68.80B |
| Alexandria Container&Cargo Handling Company | 65.91B |